Cell-El has chosen to observe the changes in these biomarkers specifically after undergoing SCT as there has been preliminary evidence that stem cells can have an immune-modulating effect on the body. See:
- Therapeutic properties of mesenchymal stem cells for autism spectrum disorders
- Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder .
Parents and clinicians have reported significant changes to the ASD related symptoms after SCT. Cell-El is now investigating if there is an underlying biomedical dysfunction prior to treatment as well as any treatment induced changes both biomedically and as evidenced by improved outward behaviors and symptoms. We hope that Improving our understanding of the value of these biomarkers could lead to utilizing them as a guide to diagnosis and perhaps even treatment choices for ASD.
Help Us Help You
Better diagnostics for ASD based on laboratory-measured objective biomarkers can possibly enable researchers and clinicians to provide more precise and personalized treatment. You too can make a difference in the lives of children with ASD and their families by joining the Cell-El study. Cell-El is recruiting for two of our study cohorts. We are recruiting mothers, and their infants aged 10-19 months who have not been diagnosed with ASD but who have a sibling diagnosed with ASD. Cell-El is also recruiting children diagnosed with ASD between the ages of 2-18 years old whose parents are planning to take them privately to a clinic offering Stem Cell treatment for ASD.
Please contact Leah at [email protected] or fill out the form to find out about eligibility to participate in our diagnostic study and please help spread the word about the Cell-El study. Sharing our study will enable our important biomarker diagnostic tool to be integrated into autism treatment as quickly as possible.
Please fill out Cell-El’s 4 minute survey about a potential new diagnostic tool for ASD.